CRESCENT BIOPHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
CRESCENT BIOPHARMA, INC. (CBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 3.32 million shares for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2025-05-14
- CRESCENT BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-03-31 was 3.32M shares.
- CRESCENT BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-09-30 was 18.61K shares.
- CRESCENT BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-06-30 was 0.00 shares.
- CRESCENT BIOPHARMA, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-03-31 was 73.86K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month |
|---|---|---|---|
| 2025-03-31 | 3.32M shares 10-Q · filed 2025-05-14 | ||
| 2022-09-30 | 18.61K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 18.61K shares derived: sum of 2 quarters · filed 2022-11-09 | 92.47K shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | 73.86K shares 10-Q · filed 2022-08-03 | |
| 2022-03-31 | 73.86K shares 10-Q · filed 2022-04-28 | ||
| 2021-06-30 | 24.51K shares 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |